{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:38:17Z","timestamp":1759847897724,"version":"3.40.5"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11845-020-02336-x","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T16:07:29Z","timestamp":1597162049000},"page":"639-641","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Practical experience of secukinumab in the treatment of psoriasis: experience from a single centre"],"prefix":"10.1007","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5640-7123","authenticated-orcid":false,"given":"Laoise","family":"Griffin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Boggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitriona","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kashif","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maeve","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"2336_CR1","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1056\/NEJMoa1314258","volume":"371","author":"RG Langley","year":"2014","unstructured":"Langley RG, Elewski BE, Lebwohl M et al (2014) Secukinumab in plaque psoriasis- results of two phase 3 trials. N Engl J Med 371:326\u2013338","journal-title":"N Engl J Med"},{"key":"2336_CR2","volume-title":"Designing clinical research","author":"SB Hulley","year":"2013","unstructured":"Hulley SB, Cummings SR, Browner WS et al (2013) Designing clinical research. Lippincott Williams & Wilkins, Toronto"},{"key":"2336_CR3","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/bjd.13348","volume":"172","author":"A Blauvelt","year":"2015","unstructured":"Blauvelt A, Prinz JC, Gottlieb AB et al (2015) Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE). Br J Dermatol 172:484\u20134933","journal-title":"Br J Dermatol"},{"key":"2336_CR4","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1111\/jdv.14468","volume":"32","author":"JR Georgakopoulos","year":"2017","unstructured":"Georgakopoulos JR, Ighani A, Zhou LL, Yeung J (2017) Efficacy and safety of secukinumab in treating moderate to severe plaque psoriasis in two real-world Canadian dermatology clinics: a multicentre retrospective study. J Eur Acad Dermatol Venereol. 32:e32\u2013e34. https:\/\/doi.org\/10.1111\/jdv.14468","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"2336_CR5","unstructured":"Warren RB, Barker J, Burden D et al Efficacy and safety of secukinumab in patients who have failed anti-tumour necrosis factor-\u03b1 treatment from the U.K. and Republic of Ireland: results of the SIGNATURE study. Psoriasis: From Gene to Clinic International Congress, London, Dec. 1, 2017, 13.45. http:\/\/psoriasisg2c.com\/wp-content\/uploads\/2017\/11\/Online-Psoriasis-G2C-... (page 66)"},{"key":"2336_CR6","doi-asserted-by":"publisher","unstructured":"Hughes J, George S, Khare S et al Baseline characteristics of patients with psoriasis on secukinumab from British association of dermatologist biologics and immunomodulators register vs a pooled psoriasis population from secukinumab global clinical trial programme. BJD Volume181, IssueS1, Special Issue: Abstracts for the British Association of Dermatologists 99th Annual Meeting, Liverpool, U.K., 2-4 July 2019. https:\/\/doi.org\/10.1111\/bjd.17752","DOI":"10.1111\/bjd.17752"},{"key":"2336_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/bjd.18981","volume":"183","author":"Z Yiu","year":"2020","unstructured":"Yiu Z, Mason K, Hampton P et al (2020) Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). Br J Dermatol. 183:294\u2013302","journal-title":"Br J Dermatol."},{"key":"2336_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13075-019-1882-2","volume":"21","author":"A Deodhar","year":"2019","unstructured":"Deodhar A, Mease PJ, McInnes IB et al (2019) Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data. Arthritis Res Ther 21:111","journal-title":"Arthritis Res Ther"},{"key":"2336_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijwd.2016.12.003","volume":"3","author":"ML Porter","year":"2017","unstructured":"Porter ML, Lockwood SJ, Kimball AB (2017) Update on biologic safety for patients with psoriasis during pregnancy. Int J Womens Dermatol 3:21\u201325","journal-title":"Int J Womens Dermatol"},{"key":"2336_CR10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/bjd.16901","volume":"179","author":"R Warren","year":"2018","unstructured":"Warren R, Reich K, Langley R et al (2018) Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database. Br J Dermatol 179:1205\u20131207","journal-title":"Br J Dermatol"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-020-02336-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-020-02336-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-020-02336-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T23:52:04Z","timestamp":1628639524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-020-02336-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["2336"],"URL":"https:\/\/doi.org\/10.1007\/s11845-020-02336-x","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2020,8,11]]},"assertion":[{"value":"25 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}